Cited by 1,073Neurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 472 of the 472 references it cites were found in a registry or an index.

Dopamine: Functions, Signaling, and Association with Neurological Diseases

Open access

Klein, Marianne O., Battagello, Daniella S., Cardoso, Ariel R., Hauser, David N., Bittencourt, Jackson C., Correa, Ricardo G.·2019·Cellular and Molecular Neurobiology

DOI 10.1007/s10571-018-0632-3PMC PMC11469830

Open this paper in CoChat — free account

Abstract

The dopaminergic system plays important roles in neuromodulation, such as motor control, motivation, reward, cognitive function, maternal, and reproductive behaviors. Dopamine is a neurotransmitter, synthesized in both central nervous system and the periphery, that exerts its actions upon binding to G protein-coupled receptors. Dopamine receptors are widely expressed in the body and function in both the peripheral and the central nervous systems. Dopaminergic signaling pathways are crucial to the maintenance of physiological processes and an unbalanced activity may lead to dysfunctions that are related to neurodegenerative diseases. Unveiling the neurobiology and the molecular mechanisms that underlie these illnesses may contribute to the development of new therapies that could promote a better quality of life for patients worldwide. In this review, we summarize the aspects of dopamine as a catecholaminergic neurotransmitter and discuss dopamine signaling pathways elicited through dopamine receptor activation in normal brain function. Furthermore, we describe the potential involvement of these signaling pathways in evoking the onset and progression of some diseases in the nervous system, such as Parkinson's, Schizophrenia, Huntington's, Attention Deficit and Hyperactivity Disorder, and Addiction. A brief description of new dopaminergic drugs recently approved and under development treatments for these ailments is also provided.

Integrity signals

Registry

Crossref · 10.1007/s10571-018-0632-3

Cites

472 of 472 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 401–472 of 472

Insulin, IGF-1, and Muscarinic Agonists Modulate Schizophrenia-associated Genes in Human Neuroblastoma Cells
Altar, C. A., Hunt, R. A., Jurata, L. W., Webster, M. J., Derby, E. G., Gallagher, P., Lemire, A. L., Brockman, J. A., & Laeng, P. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.031 · Cited by 49
Stable Expression of Short Interfering RNA for DT-Diaphorase Induces Neurotoxicity
Lozano, J., Muñoz, P., Nore, B. F., LeDoux, S. P., & Segura‐Aguilar, J. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100182a · Cited by 49
Distribution and hormonal regulation of androgen receptor immunoreactivity in the forebrain of the male European ferret
Kashon, M. L., Arbogast, J. A., & Sisk, C. L. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961223)376:4 · Cited by 48
RGS9‐2 mediates specific inhibition of agonist‐induced internalization of D2‐dopamine receptors
Celver, J. P., Sharma, M., & Kovoor, A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06805.x · Cited by 47
The GSK3 Signaling Pathway Is Activated by Cocaine and Is Critical for Cocaine Conditioned Reward in Mice
Miller, J. S., Barr, J. L., Harper, L. J., Poole, R. L., Gould, T. J., & Unterwald, E. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088026 · Cited by 47
Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer’s disease: An autopsy-confirmed study
Morimoto, S., Takao, M., Hatsuta, H., Nishina, Y., Komiya, T., Sengoku, R., Nakano, Y., Uchino, A., Sumikura, H., Saito, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171524 · Cited by 47
The Distribution and Morphological Characteristics of Catecholaminergic Cells in the Diencephalon and Midbrain of the Bottlenose Dolphin (Tursiops truncatus)
Manger, P. R., Fuxé, K., Ridgway, S. H., & Siegel, J. M. (2004) · Brain Behavior and Evolution · doi:10.1159/000077542 · Cited by 46
Locomotor activity elicited by injections of picrotoxin into the ventral tegmental area is attenuated by injections of GABA into the globus pallidus
Mogenson, G. J., Wu, M., & Jones, D. L. (1980) · Brain Research · doi:10.1016/0006-8993(80)91308-6 · Cited by 43
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes
Missale, C., Fiorentini, C., Collo, G., & Spano, P. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2010.506192 · Cited by 42
An update on Huntington's disease
Kim, S. D., & Fung, V. S. C. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000116 · Cited by 42
Preclinical pharmacology and pharmacokinetics of CERC‐301, a GluN2B‐selectiveN‐methyl‐D‐aspartate receptor antagonist
Garner, R. M., Gopalakrishnan, S., McCauley, J. A., Bednar, R. A., Gaul, S. L., Mosser, S. D., Kiss, L., Lynch, J. J., Patel, S., Fandozzi, C. M., et al. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.198 · Cited by 42
Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists
Xu, W., Wang, X., Tocker, A. M., Huang, P., Reith, M. E. A., Liu‐Chen, L., Smith, A. B., & Kortagere, S. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00221 · Cited by 41
Cariprazine: New dopamine biased agonist for neuropsychiatric disorders
Deurwaerdère, P. D. (2016) · Drugs of today · doi:10.1358/dot.2016.52.2.2461868 · Cited by 40
Absence of short-loop autoregulation of prolactin during late pregnancy in the rat
Grattan, D. R., & AVERILL, R. L. W. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00216-n · Cited by 39
Dopamine D2Receptor-Activated Ca2+Signaling Modulates Voltage-Sensitive Sodium Currents in Rat Nucleus Accumbens Neurons
Hu, X., Dong, Y., Zhang, X.-F., & White, F. J. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00771.2004 · Cited by 39
The involvement of DARPP-32 in the pathophysiology of schizophrenia
Wang, H., Farhan, M., Xu, J., Lazarovici, P., & Zheng, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17339 · Cited by 38
The Importance of Mitophagy in Maintaining Mitochondrial Function in U373MG Cells. Bafilomycin A1 Restores Aminochrome-Induced Mitochondrial Damage
Huenchuguala, S., Muñoz, P., & Segura‐Aguilar, J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00152 · Cited by 38
Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease
Segura‐Aguilar, J., & Huenchuguala, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00106 · Cited by 38
Agonist Action at D2(short) Dopamine Receptors Determined in Ligand Binding and Functional Assays
Gardner, B. R., Hall, D. A., & Strange, P. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062589.x · Cited by 37
RGS Proteins: Swiss Army Knives in Seven-Transmembrane Domain Receptor Signaling Networks
Heximer, S. P., & BLUMER, K. J. (2007) · Science s STKE · doi:10.1126/stke.3702007pe2 · Cited by 36
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis.
Martelli, A. M., Chiarini, F., Evangelisti, C., Grimaldi, C., Ognibene, A., Manzoli, L., Billi, A. M., & McCubrey, J. A. (2010) · PubMed · doi:10.14670/hh-25.669 · Cited by 35
Distinct Cellular and Subcellular Distributions of G Protein-Coupled Receptor Kinase and Arrestin Isoforms in the Striatum
Бычков, Э. Р., Zurkovsky, L., Garret, M. B., Ahmed, M. R., & Gurevich, E. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048912 · Cited by 35
The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs
Rossi, M., Fasciani, I., Marampon, F., Maggio, R., & Scarselli, M. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107607 · Cited by 35
Dopamine D1 Receptor Signaling: Does GαQ–Phospholipase C Actually Play a Role?
Lee, S. M., Yang, Y., & Mailman, R. B. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214411 · Cited by 34
Huntington's Disease in Black Kindreds in South Carolina
Wright, H. H., Still, C. N., & Abramson, R. K. (1981) · Archives of Neurology · doi:10.1001/archneur.1981.00510070046005 · Cited by 34
Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D2 Receptor Controls Cocaine’s Neurochemical Actions
Asif-Malik, A., Hoener, M. C., & Canales, J. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-14472-z · Cited by 34
GABAergic mechanisms within the ventral tegmental area: Involvement of dopaminergic (A 10) and non-dopaminergic neurones
Stinus, L., Herman, J. P., & Moal, M. L. (1982) · Psychopharmacology · doi:10.1007/bf00431946 · Cited by 33
Brexpiprazole: a new dopamine D2 receptor partial agonist for the treatment of schizophrenia and major depressive disorder
Citrome, L. (2015) · Drugs of today · doi:10.1358/dot.2015.51.7.2358605 · Cited by 33
Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats
Pan, B., Chen, J., Lian, J., Huang, X., & Deng, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132722 · Cited by 32
Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β‐arrestin interactions
Gao, Y., Peterson, S. M., Masri, B., Hougland, M. T., Adham, N., Gyertyán, I., Kiss, B., Caron, M. G., & El‐Mallakh, R. S. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.73 · Cited by 32
Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution
Nishi, A., Matamales, M., Musante, V., Valjent, E., Kuroiwa, M., Kitahara, Y., Rebholz, H., Greengard, P., Girault, J., & Nairn, A. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752402 · Cited by 32
RGS Proteins: G Protein-Coupled Receptors Meet Their Match
Chasse, S., & Dohlman, H. G. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803764958649 · Cited by 31
Regulators of G-Protein-Signaling Proteins: Negative Modulators of G-Protein-Coupled Receptor Signaling
Woodard, G. E., Jardín, I., Berna‐Erro, A., Salido, G. M., & Rosado, J. A. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.02.001 · Cited by 30
DT-diaphorase protects astrocytes from aminochrome-induced toxicity
Huenchuguala, S., Muñoz, P., Graumann, R., Paris, I. B., & Segura‐Aguilar, J. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.04.014 · Cited by 30
Dopamine inhibits a sustained calcium current through activation of alpha adrenergic receptors and a GTP-binding protein in adult rat sympathetic neurons.
Aguayo, L. G., & Grossie, J. A. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38735-5 · Cited by 29
Prolactin and growth hormone secretion after thyrotrophin-releasing hormone infusion and dopaminergic (DA2) blockade in infertile patients with minimal/mild endometriosis
Cunha‐Filho, J. S. (2002) · Human Reproduction · doi:10.1093/humrep/17.4.960 · Cited by 29
Short- and long-lasting behavioral and neurochemical adaptations: relationship with patterns of cocaine administration and expectation of drug effects in rats
Puig, S., Noble, F., & Benturquia, N. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.103 · Cited by 28
Roles of G protein and β-arrestin in dopamine D 2 receptor-mediated ERK activation
Quan, W., Kim, J.-H., Albert, P. R., Choi, H., & Kim, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.044 · Cited by 27
Selective inhibition of dopamine‐beta‐hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex
Devoto, P., Flore, G., Saba, P., Frau, R., & Gessa, G. L. (2015) · Brain and Behavior · doi:10.1002/brb3.393 · Cited by 27
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist
Moritz, A. E., Free, R. B., Weiner, W. S., Akano, E. O., Gandhi, D. M., Abramyan, A. M., Keck, T. M., Ferrer, M., Hu, X., Southall, N. T., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00424 · Cited by 26
Dopamine binds to α2-adrenergic receptors in the song control system of zebra finches (Taeniopygia guttata)
Cornil, C. A., Castelino, C. B., & Ball, G. F. (2007) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2007.10.004 · Cited by 25
Dopamine D1 Receptor Regulation of Phospholipase C
José, P. A., Yu, P., Yamapchi, I., Eisner, G. M., Mouradian, M. M., Felder, C. C., & Felder, R. A. (1995) · Hypertension Research · doi:10.1291/hypres.18.supplementi_s39 · Cited by 25
Dopamine induces intracellular Ca2+ signals mediated by α1B-adrenoceptors in rat pineal cells
Rey, E., Hernández-Díaz, F., Abreu, P. M., Alonso, R., & Tabares, L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01250-x · Cited by 24
Novel Diels–Alder Type Adducts from Morus alba Root Bark Targeting Human Monoamine Oxidase and Dopaminergic Receptors for the Management of Neurodegenerative Diseases
Paudel, P., Park, S. E., Seong, S. H., Jung, H. A., & Choi, J. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246232 · Cited by 24
Dop1R1, a type 1 dopaminergic receptor expressed in Mushroom Bodies, modulates Drosophila larval locomotion
Silva, B., Hidalgo, S., & Campusano, J. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229671 · Cited by 24
D2-Like Receptors Mediate Dopamine-Inhibited Insulin Secretion via Ion Channels in Rat Pancreatic β-Cells
Liu, M., Ren, L., Zhong, X., Ding, Y., Liu, T., Liu, Z., Yang, X., Cui, L., Yang, L., Fan, Y., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00152 · Cited by 24
Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons
Ledonne, A., Berretta, N., Davoli, A., Rizzo, G. R., Bernardi, G., & Mercuri, N. B. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00056 · Cited by 23
On the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo
Herrera-Soto, A., Díaz‐Véliz, G., Mora, S., Muñoz, P., Henny, P., Steinbusch, H. W. M., & Segura‐Aguilar, J. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9719-8 · Cited by 22
Relationship Between Hypothalamic and Median Eminence Catecholamines and Thyroid Function
Brown, G. M., Krigstein, E., Dankova, J., & Hornykiewicz, O. (2008) · Neuroendocrinology · doi:10.1159/000122090 · Cited by 21
Dopamine receptor D4 internalization requires a beta-arrestin and a visual arrestin
Deming, J. D., Shin, J., Lim, K., Lee, E.-J., Craenenbroeck, K. V., & Craft, C. M. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.06.008 · Cited by 20
Combined Microdialysis and Fos Immunohistochemistry for the Estimation of Dopamine Neurotransmission in the Rat Caudate‐Putamen
Morelli, M., Carboni, E., Cozzolino, A., Tanda, G., Pinna, A., & Chiara, G. D. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08359.x · Cited by 20
Noncoding RNA Regulation of Dopamine Signaling in Diseases of the Central Nervous System
Carrick, W. T., Burks, B., Cairns, M. J., & Kocerha, J. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00069 · Cited by 19
Lithium normalizes amphetamine-induced changes in striatal FoxO1 phosphorylation and behaviors in rats
Zheng, W., Zeng, Z., Bhardwaj, S. K., Jamali, S., & Srivastava, L. K. (2013) · Neuroreport · doi:10.1097/wnr.0b013e3283623725 · Cited by 18
A new D2 dopamine receptor agonist allosterically modulates A2A adenosine receptor signalling by interacting with the A2A/D2 receptor heteromer
Trincavelli, M. L., Daniele, S., Orlandini, E., Navarro, G., Casadó, V., Giacomelli, C., Nencetti, S., Nuti, E., Macchia, M., Huebner, H., et al. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.018 · Cited by 18
Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C
Sahin, B., Hawasli, A. H., Greene, R. W., Molkentin, J. D., & Bibb, J. A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.061 · Cited by 17
Molecular Characterization of Dopamine D2 Receptor Isoforms Tagged With Green Fluorescent Protein
Sedaghat, K., Nantel, M., Ginsberg, S., Lalonde, V., & Tiberi, M. (2006) · Molecular Biotechnology · doi:10.1385/mb:34:1:1 · Cited by 17
Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: Examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia
Tan, M. L., Basu, D., Kwiecień, J. M., Johnson, R. L., & Mishra, R. K. (2013) · Peptides · doi:10.1016/j.peptides.2013.02.004 · Cited by 17
Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
Xu, K., Näveri, L., Frerichs, K. U., Hallenbeck, J. M., Feuerstein, G. Z., Davis, J. N., & Sirén, A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39345-6 · Cited by 15
Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice
Gómez‐Sintes, R., Bortolozzi, A. A., Artigas, F., & Lucas, J. J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.004 · Cited by 14
Stimulation of prolactin release by dopamine withdrawal: role of calcium influx
Gregerson, K. A., Chuknyiska, R. S., & Golesorkhi, N. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.5.e789 · Cited by 14
Dopamine D2L receptor-interacting proteins regulate dopaminergic signaling
Shioda, N. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.10.002 · Cited by 14
Differential α2‐mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade
Valentini, V., Cacciapaglia, F., Frau, R., & Chiara, G. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03851.x · Cited by 12
Schizophrenia
Meyer, N., & MacCabe, J. H. (2016) · Medicine · doi:10.1016/j.mpmed.2016.08.003 · Cited by 12
Transmission of Nervous Effects by Acetylcholine: Harvey Lecture, May 20, 1937.
Dale, H. H. (1937) · PubMed · Cited by 10
Oral biomarkers in exercise‐induced neuroplasticity in Parkinson's disease
Mougeot, J., Hirsch, M. A., Stevens, C. B., & Mougeot, F. K. B. (2016) · Oral Diseases · doi:10.1111/odi.12463 · Cited by 8
History of Catecholamine Research
Starke, K. (2014) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000359962 · Cited by 7
Chapter 54 The discovery of neurotransmitters, and applications to neurology
Sourkes, T. L. (2009) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)02154-4 · Cited by 7
Of Mice and Men: What Physiological Correlates of Cognitive Deficits in a Mouse Model of Schizophrenia Tell Us about Psychiatric Disease
O’Donnell, P. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.012 · Cited by 6
Biochemical Composition during the Embryonic Development and Freshly Hatched Zoea of Macrobrachium idella idella (Hilgendorf, 1898)
Soundarapandian, P., Dinakaran, G. K., & Varadharajan, D. (2013) · Advanced Techniques in Biology & Medicine · doi:10.4172/2167-065x.1000111 · Cited by 6
Expression of GluA2-containing calcium-impermeable AMPA receptors on dopaminergic amacrine cells in the mouse retina.
Liu, L., Alessio, E. J., Spix, N. J., & Zhang, D.-Q. (2019) · PubMed Central · Cited by 6
Activation of D1-like receptor-dependent phosphatidylinositol signal pathway by SKF83959 inhibits voltage-gated sodium channels in cultured striatal neurons
Ma, J., Long, L., Hu, Z., Zhang, H., Han, J., Ni, L., Wang, F., Chen, J., & Wu, P. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.030 · Cited by 5
Stem Cell-Derived Neurons for the Treatment of Neurodegenerative Diseases
Gu, H. (2013) · Clinical Pharmacology & Biopharmaceutics · Cited by 4

Flagged first, then by citations

Research works printed but not linked: 4

Dale H (1935) Pharmacology and nerve-endings: Walter Ernest Dixon Memorial Lecture. Proc R Soc Med 28:319–332
Faraone SV, Sergeant J, Gillberg C, Biederman J (2003) The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104
Hohman LB (1922) Post-encephalitic behavior disorders in children. Johns Hopkins Hospt Bull 33:372–375
Stryker S (1925) Encephalitis lethargica—the behavior residuals. Train Sch Bull (Vinel) 22:152–157

Sorted by citations

Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System
Teleanu, R. I., Niculescu, A.-G., Roza, E., Vladâcenco, O. A., Grumezescu, A. M., & Teleanu, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115954 · Cited by 659
Next-generation GRAB sensors for monitoring dopaminergic activity in vivo
Sun, F., Zhou, J., Dai, B., Qian, T., Zeng, J., Li, X., Zhuo, Y., Zhang, Y., Wang, Y., Cheng, Q., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-00981-9 · Cited by 483
Dopamine in Parkinson's disease
Latif, S., Jahangeer, M., Razia, D. E. M., Ashiq, M., Ghaffar, A., Akram, M., Allam, A. E., Bouyahya, A., Garipova, L., Shariati, M. A., et al. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.08.009 · Cited by 374
Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336
Electrochemical Biosensing of Dopamine Neurotransmitter: A Review
Lakard, S., Pavel, I., & Lakard, B. (2021) · Biosensors · doi:10.3390/bios11060179 · Cited by 245

See all 1,073

Authors: Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G.
Affiliations: Universidade de São Paulo (BR)
Sanford Burnham Prebys Medical Discovery Institute (US)
Corresponding author: Bittencourt, Jackson C.
Correa, Ricardo G.
ORCID: Klein, Marianne O.
Battagello, Daniella S.
Cardoso, Ariel R.
Hauser, David N.
Bittencourt, Jackson C.
Correa, Ricardo G.
Venue: Cellular and Molecular Neurobiology
Publisher: Springer Science and Business Media LLC
Published: 2018-11-16
Volume: 39
Issue: 1
Pages: 31-59
ISSN: 0272-4340 (ISSN-L)
1573-6830
DOI: 10.1007/s10571-018-0632-3
PMC: PMC11469830
OpenAlex: W2901208536
Cited by: 1,073
References: 472
Citations by year: 2026: 141 · 2025: 174 · 2024: 214 · 2023: 199 · 2022: 148 · 2021: 105 · 2020: 64 · 2019: 27
FWCI: 6.41
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Cellular and Molecular Neurobiology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: dopamine, dopaminergic signaling, dopamine receptors, G protein-coupled receptors, catecholamine neurotransmitters, neuromodulation, neurodegenerative diseases, Parkinson's disease, schizophrenia, Huntington's disease, attention deficit hyperactivity disorder, addiction, dopaminergic therapy, reward and motivation
MeSH terms: Animals, Brain, Dopamine, Humans, Models, Biological, Nervous System Diseases, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dopamine: Functions, Signaling, and Association with Neurological Diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks